目的探讨肾功能不全患者止血与抗凝的个体化给药方案。方法在医师给药方案基础上,临床药师通过参与临床查房,关注患者的生理病理特征,通过血药浓度及效应的监测,为患者制定了个体化的止血与抗凝方案。结果患者手术中及手术后总失血量为3...目的探讨肾功能不全患者止血与抗凝的个体化给药方案。方法在医师给药方案基础上,临床药师通过参与临床查房,关注患者的生理病理特征,通过血药浓度及效应的监测,为患者制定了个体化的止血与抗凝方案。结果患者手术中及手术后总失血量为360 m L,凝血指标控制在正常范围内,手术后无静脉血栓形成。结论临床药师结合患者特征及药物作用特点,对患者进行个体化给药建议,保证了围手术期止血与抗凝的有效性和安全性。展开更多
In order to know some organic byproducts formed during composing 1,3,5-triamion-2,4, 6-trinitrobenzene (TATB), the components in toluene mother solution of TATB were separated and identified by gas chromatography-mass...In order to know some organic byproducts formed during composing 1,3,5-triamion-2,4, 6-trinitrobenzene (TATB), the components in toluene mother solution of TATB were separated and identified by gas chromatography-mass spectrometry (GC/MS). The results showed that the impurities of trichlorodinitrobenzene, trichlorotrinitrobenzene, tetrachlorodinitrobenzene, dinichlorot rinit roaniline and trichlorodinitroaniline presented in toluene solution of TATB.展开更多
文摘目的探讨肾功能不全患者止血与抗凝的个体化给药方案。方法在医师给药方案基础上,临床药师通过参与临床查房,关注患者的生理病理特征,通过血药浓度及效应的监测,为患者制定了个体化的止血与抗凝方案。结果患者手术中及手术后总失血量为360 m L,凝血指标控制在正常范围内,手术后无静脉血栓形成。结论临床药师结合患者特征及药物作用特点,对患者进行个体化给药建议,保证了围手术期止血与抗凝的有效性和安全性。
文摘In order to know some organic byproducts formed during composing 1,3,5-triamion-2,4, 6-trinitrobenzene (TATB), the components in toluene mother solution of TATB were separated and identified by gas chromatography-mass spectrometry (GC/MS). The results showed that the impurities of trichlorodinitrobenzene, trichlorotrinitrobenzene, tetrachlorodinitrobenzene, dinichlorot rinit roaniline and trichlorodinitroaniline presented in toluene solution of TATB.